Viewing Study NCT06005532


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-06-26 @ 3:00 PM
Study NCT ID: NCT06005532
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
Sponsor: Mabscale, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Psoriasis View
Keywords: